| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.2 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.2 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |